Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jay Acharya

Neuroradiology West Hollywood, CA Medical Doctor

NPI 1871995498 CMS profile 1946752

8700 Beverly Blvd, West Hollywood, CA 90048

Open in the dashboard

General payments

$127,920

207 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$26,858 paid to institutions, not to them · program years 2021–2022

Through program year 2025, Jay Acharya of West Hollywood, CA is reported in the CMS Open Payments database as having received $127,920 across 207 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $26,858 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Neuroradiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,969 9
2024 General $17,964 36
2023 General $50,049 65
2022 General $24,933 33
2021 General $5,776 13
2020 General $13,997 35
2019 General $10,233 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jay Acharya
  • Neuroradiology median
  • Middle half of Neuroradiology
  • National median

In program year 2025, general payments to Jay Acharya were reported at $4,969. Among 399 Neuroradiology profiles paid that year, the median was $279 and the middle half received between $65 and $2,205.

Show as a table
Year Jay Acharya Neuroradiology median Middle half National median
2019 $10,233 $288 $71–$2,035 $163
2020 $13,997 $165 $32–$1,794 $114
2021 $5,776 $238 $42–$1,807 $132
2022 $24,933 $191 $49–$1,388 $149
2023 $50,049 $228 $56–$1,148 $160
2024 $17,964 $241 $97–$2,192 $164
2025 $4,969 $279 $65–$2,205 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $85,572 120 payments
  2. Medtronic USA, Inc. $13,898 36 payments
  3. Bard Peripheral Vascular, Inc. $10,724 4 payments
  4. Siemens Medical Solutions USA, Inc. $10,243 14 payments
  5. Medtronic, Inc. $5,869 13 payments
  6. Boston Scientific Corporation $1,228 14 payments
  7. icotec Medical Inc. $187 3 payments
  8. Nevro Corp. $128 1 payment
  9. AngioDynamics, Inc. $47 1 payment
  10. Biogen, Inc. $23 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $83,375 29 payments
  2. Travel and Lodging $20,868 60 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $16,900 8 payments
  4. Food and Beverage $6,777 110 payments
Products named General payments · program years 2019–2025
  1. AUTOPLEX $38,248 18 payments
  2. SPINEJACK $31,107 58 payments
  3. AVAFLEX $30,005 13 payments
  4. OPTABLATE $24,144 26 payments
  5. SPINEPLEX $18,872 11 payments
  6. VERTAPLEX $17,074 7 payments
  7. IVAS $15,972 18 payments
  8. PCD $9,808 5 payments
  9. NA $9,571 4 payments
  10. DISCMONITOR $9,571 4 payments
  11. Other $49,110 102 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 108 billing codes

Paid by Medicare

$326,217

Of which drugs: $6,900

Medicare patients

2,212

Average age 74

Services billed

33,288

1,250 women, 962 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 68%
Ischemic heart disease 42%
Diabetes 38%
Depression 36%
Chronic kidney disease 29%
Heart failure 26%
Osteoporosis 26%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, gadobutrol, 0.1 ml A9585 Office 304 25,908 $6,480
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 40 3,820 $399

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

207 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neuroradiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record